Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

A live attenuated human rotavirus vaccine, designated as RV1, is administered orally in a two-dose schedule. This vaccine is specifically designed to provide long-term immunity against rotavirus, a highly contagious virus that is a leading cause of severe gastroenteritis in infants and young children. Unlike immune globulins, which offer only short-term, passive immunity, vaccines like RV1 stimulate the recipient's immune system to produce its own antibodies. This process involves exposing the immune system to a modified version of the virus, which helps the body learn to recognize and combat the actual virus in the future. Rotavirus infection is prevalent, with nearly every child in the United States experiencing it by the age of five, often resulting in multiple episodes of vomiting and severe diarrhea that may necessitate hospitalization. The RV1 vaccine contains a weakened strain of the rotavirus, ensuring safety while effectively preparing the immune system to respond to future infections. It is important to note that this CPT® code specifically reports the supply of the vaccine and does not include the oral administration of the vaccine itself.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The rotavirus vaccine (RV1) is indicated for the prevention of rotavirus disease in infants and young children. The following conditions highlight the necessity of this vaccination:

  • Prevention of Rotavirus Infection The vaccine is administered to protect against rotavirus, which is known to cause severe gastroenteritis characterized by vomiting and diarrhea.
  • Reduction of Hospitalization Risk By immunizing children against rotavirus, the vaccine aims to decrease the incidence of severe cases that may require hospitalization.
  • Protection for Infants and Young Children The vaccine is specifically designed for use in infants and children, as they are the most vulnerable to the complications associated with rotavirus infection.

2. Procedure

The administration of the rotavirus vaccine (RV1) follows a structured procedure to ensure proper immunization. The steps involved are as follows:

  • Step 1: Preparation of the Vaccine The vaccine is prepared according to the manufacturer's guidelines, ensuring that it is stored at the appropriate temperature and is within its expiration date. This step is crucial to maintain the vaccine's efficacy.
  • Step 2: Patient Assessment Prior to administration, a healthcare provider assesses the patient’s medical history to confirm that there are no contraindications to receiving the vaccine. This includes checking for any previous allergic reactions to vaccines or components of the rotavirus vaccine.
  • Step 3: Administration of the Vaccine The vaccine is administered orally, typically in two doses. The first dose is given at 2 months of age, followed by a second dose at 4 months of age. The healthcare provider ensures that the child swallows the vaccine completely to achieve optimal immunization.
  • Step 4: Post-Administration Monitoring After the administration of the vaccine, the child is monitored for a short period to observe for any immediate adverse reactions. This is a standard precautionary measure to ensure the safety of the patient.

3. Post-Procedure

Following the administration of the rotavirus vaccine, it is important to provide appropriate post-procedure care. Parents or guardians should be informed about potential mild side effects, which may include irritability, mild diarrhea, or vomiting. These symptoms are generally short-lived and resolve without intervention. It is also essential to advise caregivers to monitor the child for any unusual reactions and to contact a healthcare provider if severe symptoms occur. The child should continue to receive routine pediatric care and follow-up vaccinations as per the recommended immunization schedule.

Short Descr RV1 VACC 2 DOSE LIVE ORAL
Medium Descr RV1 VACCINE 2 DOSE SCHEDULE LIVE FOR ORAL USE
Long Descr Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Not Billable to the MAC
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE 1
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
Date
Action
Notes
2016-01-01 Changed First appearance of change in codebook.
2015-07-01 Changed Description Changed
2009-01-01 Added First appearance in code book in 2009.
2008-01-01 Added -
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"